José Angel
García Rodríguez
GlaxoSmithKline (Spain)
Madrid, EspañaPublications en collaboration avec des chercheurs de GlaxoSmithKline (Spain) (6)
2005
-
Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain
Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972
-
Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: Mechanisms of resistance and clonal diversity
Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 1, pp. 418-420
2003
-
Evolution of penicillin and erythromycin co-resistance in Streptococcus pneumoniae in Spain
International Journal of Antimicrobial Agents, Vol. 22, Núm. 5, pp. 541-544
2002
-
Activities of six different quinolones against clinical respiratory isolates of streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain
Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 8, pp. 2665-2667
-
Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]
Journal of Antimicrobial Chemotherapy
2001
-
Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999
Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 11, pp. 3226-3228